Immune infiltration analysis revealed a significant positive correlation between the expression levels of LOXL1, OSMR, and STOX1 and immune scores, suggesting that these genes may influence the TME and hold potential as therapeutic targets in GBM. This evidence concerns the gene STOX1 and glioblastoma.